Su1816 COST-EFFECTIVENESS OF 5-ASA THERAPY IN COMBINATION WITH BIOLOGICS OR TOFACITINIB IN THE TREATMENT OF ULCERATIVE COLITIS

2020 
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    0
    Citations
    NaN
    KQI
    []